Comparison of Delta-Shaped and Billroth II After TLDG

Comparison of Delta-Shaped and Billroth II for Intracorporeal Anastomosis After Totally Laparoscopic Distal Gastrectomy for Gastric Cancer

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT02372747

Acronym

TLDG

Enrollment

Registered

2015-02-26

Start date

2012-10-31

Completion date

2014-12-31

Last updated

2015-02-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastric Cancer

Keywords

Totally laparoscopic gastrectomy, laparoscopic distal gastrectomy, Intracorporeal anastomosis, Delta-Shaped Anastomosis, Billroth II Anastomosis, Gastric cancer

Brief summary

To compare the safety and feasibility of Delta-shaped anastomosis and Billroth II anastomosis after totally laparoscopic distal gastrectomy for gastric cancer(TLDG).

Detailed description

Methods: 78 consecutive patients who underwent TLDG in First Hospital of Jilin University between October 2012 and December 2014 were enrolled in this study . All patients were divided randomly into two groups:Delta-shaped anastomosis group (DS group) and Billroth II anastomosis group (B-II group), and the patients in DS group underwent Delta-shaped anastomosis after TLDG, and the patients in B-II group underwent Billroth-II anastomosis after TLDG.Outcome measures,resected margin,operative time,anastomosis time,number of stapler cartridges used,length of the incision,the time of first flatus and liquid diet,hospital stay and postoperative morbidity are compared between the two groups.

Interventions

PROCEDUREDelta-shaped anastomosis

The patients in DS group underwent Delta-shaped anastomosis after TLDG.

PROCEDUREBillroth II anastomosis

The patients in B-II group underwent Billroth-II anastomosis after TLDG.

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

SUPPORTIVE_CARE

Masking

SINGLE (Subject)

Eligibility

Sex/Gender

ALL

Healthy volunteers

Inclusion criteria

* carcinoma located in the lower 1/3 of gastric body or antrum of stomach * diagnosed by endoscopy ,endoscopic ultrasonography and abdominal CT scan * diameter of the tumor \<3cm * no pyloric obstruction

Exclusion criteria

* diameter of the tumor ≥3cm * associated with obstruction, bleeding, emergency surgery or surgical intervention * tumor with extensive metastasis * patient had previously undergone gastrostomy

Design outcomes

Primary

Measure	Time frame
Length of the incision	up to 7 days after the operation
Stage distribution	up to 7 days after the operation
Resected margin	up to 7 days after the operation
Operative time	up to 7 days after the operation
Anastomosis time	up to 7 days after the operation
The number of stapler cartridges used	up to 7 days after the operation
Median estimated blood loss	up to 7 days after the operation
Red blood cell transfusion	up to 7 days after the operation

Secondary

Measure	Time frame	Description
Postoperative complication	up to 30 days after the operation	Major complications includes anastomosis leakage and intrabdominal bleeding . Minor complications includes bile regurgitation,anastomotic stenosis and delayed gastric emptying.

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026